UCB Korea holds Vimpat symposium

Published: 2012-01-25 06:57:00

Updated: 2012-01-25 06:57:00

Scores of neurologists and pediatricians at home and abroad gathered in Seoul and Busan between January 13 and 14 to participate in a launching symposium of Vimpat (lacosamide) on the future strategy of epilepsy.

The theme of the two-day symposium, organized by UCB Korea, is “Insight into Epil...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK